Search

Your search keyword '"Clifford R. Jack, Jr"' showing total 70 results

Search Constraints

Start Over You searched for: Author "Clifford R. Jack, Jr" Remove constraint Author: "Clifford R. Jack, Jr"
70 results on '"Clifford R. Jack, Jr"'

Search Results

1. Validating a Portable, Camera-Based System to Scale the Clinical Gait Assessment as a Tele-Health Solution

2. Altered structural and functional connectivity in Posterior Cortical Atrophy and Dementia with Lewy bodies

3. Speech-language within and between network disruptions in primary progressive aphasia variants

4. Complex relationships of socioeconomic status with vascular and Alzheimer’s pathways on cognition

5. The diamagnetic component map from quantitative susceptibility mapping (QSM) source separation reveals pathological alteration in Alzheimer’s disease-driven neurodegeneration

6. A face-off of MRI research sequences by their need for de-facing

7. Cross–scanner harmonization methods for structural MRI may need further work: A comparison study

8. Spatial patterns of elevated magnetic susceptibility in progressive apraxia of speech

9. Face recognition from research brain PET: An unexpected PET problem

11. TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration

12. Distinct brain iron profiles associated with logopenic progressive aphasia and posterior cortical atrophy

13. Relationships between β-amyloid and tau in an elderly population: An accelerated failure time modelww

14. Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation

15. CSF dynamics as a predictor of cognitive progression

16. Changing the face of neuroimaging research: Comparing a new MRI de-facing technique with popular alternatives

17. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers

18. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease

19. 18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus

20. Disrupted functional connectivity in primary progressive apraxia of speech

21. Comparison of [18F]Flutemetamol and [11C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals

22. Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease

23. Automated detection of imaging features of disproportionately enlarged subarachnoid space hydrocephalus using machine learning methods

24. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease

25. Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging

32. Tau Polygenic Risk Scoring: a Cost-Effective Aid for Prognostic Counseling in Alzheimer’s Disease

33. Causal Structure Discovery Identifies Risk Factors and Early Brain Markers Related to Evolution of White Matter Hyperintensities

35. Practical algorithms for amyloid β probability in subjective or mild cognitive impairment

36. Deep learning identifies brain structures that predict cognition and explain heterogeneity in cognitive aging

37. Amyloid-PET and ¹⁸F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementia

38. Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease

41. Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging

42. Population-Based Prevalence of Infarctions on 3D Fluid-Attenuated Inversion Recovery (FLAIR) Imaging.

43. NODDI in gray matter is a sensitive marker of aging and early AD changes

44. Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology

45. Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline

46. Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration

47. Plasma‐derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community‐based study

48. Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research

49. Deep learning identifies brain structures that predict cognition and explain heterogeneity in cognitive aging

50. MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous

Catalog

Books, media, physical & digital resources